13 November 2024
Did you know that over 40% of biotherapeutic drug failures during clinical development are linked to stability issues, with protein aggregation being a primary culprit? For biologics manufacturers, […]
13 November 2024
In the world of biotherapeutic manufacturing, there are few issues as pervasive and critical as protein aggregation. Despite its “silent” nature, protein aggregation can have profound […]
13 November 2024
In the world of biotherapeutic manufacturing, there are few issues as pervasive and critical as protein aggregation. Despite its “silent” nature, protein aggregation can have profound […]
